Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Cullinan Therapeutics Inc fell by 57.72m. Cash Flow from Financing totalled 40.75m or -- of revenues. In addition the company used 134.28m for operations while cash from investing totalled 35.81m.
Cash flow per share | -2.92 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 10.80 |
---|---|
Tangible book value per share | 10.80 |
More ▼
Balance sheet in USDView more
Current ratio | 24.46 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼